Dabrafenib Mesylate (GSK-2118436B)

Biorbyt

Dabrafenib Mesylate (GSK-2118436B) [1195768-06-9]

16

1195768-06-9

Research Use Only

C24H24F3N5O5S3

615.6681

Dabrafenib is an orally bioavailable inhibitor of B-raf (BRAF) protein with potential antineoplastic activity.

S1C(C2C([H])=C([H])N=C(N([H])[H])N=2)=C(C2C([H])=C([H])C([H])=C(C=2F)N([H])S(C2C(=C([H])C([H])=C([H])C=2F)F)(=O)=O)N=C1C(C([H])([H])[H])(C([H])([H])[H])C([H])([H])[H].S(C([H])([H])[H])(=O)(=O)O[H]

12352200